Comparison of topical and intravenous tranexamic acid on blood loss and transfusion rates in total hip arthroplasty.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 25155138.
- Also identified by DOI 10.1016/j.arth.2014.07.019.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The objective of this study was to determine whether topical tranexamic acid (TXA) carried similar hemostatic effect compared with intravenous TXA in total hip arthroplasty (THA). Three hundred and three THA patients were enrolled and randomized into 3 groups: no TXA group, topical and intravenous TXA group. The results showed that the topical and intravenous TXA group had reduced but similar blood transfusion rates (5.88% v. s. 5.94%, P = 0.816). No significant difference was detected in total blood loss between the two TXA groups [(963.4 ± 421.3) ml vs. (958.5 ± 422) ml P = 0.733]. We conclude that topical use of TXA was equally effective and safe compared with intravenous TXA in reducing blood loss and transfusion rate following THA without substantial complications.
Medical subject headings
- Antifibrinolytic Agents
- Arthroplasty, Replacement, Hip
- Tranexamic Acid
Anatomy
- hip